2016
DOI: 10.3390/inorganics4040038
|View full text |Cite
|
Sign up to set email alerts
|

Steroid-Functionalized Titanocenes: Docking Studies with Estrogen Receptor Alpha

Abstract: Estrogen receptor alpha (ERα) is a transcription factor that is activated by hormones, with 17β-estradiol being its most active agonist endogenous ligand. ERα is also activated or inactivated by exogenous ligands. ER is overexpressed in hormone-dependent breast cancer, and one of the treatments for this type of cancer is the use of an ER antagonist to halt cell proliferation. We have previously reported four steroid-functionalized titanocenes: pregnenolone, dehydroepiandrosterone (DHEA), trans-androsterone, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 32 publications
0
8
0
Order By: Relevance
“…However, Cp2TiCl2 did not advance in clinical trials owing to its low efficacy against the examined tumours and because of its inherent limitations such as poor water-solubility and instability, the latter due to extensive hydrolysis [13][14][15]. In spite of the unsatisfactory results of the phase II clinical trials, various researchers have continued investigations into titanium-based drugs, sparking interest in the synthesis of secondgeneration titanocene and titanium(IV) complexes with anti-cancer properties [16][17][18][19][20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%
“…However, Cp2TiCl2 did not advance in clinical trials owing to its low efficacy against the examined tumours and because of its inherent limitations such as poor water-solubility and instability, the latter due to extensive hydrolysis [13][14][15]. In spite of the unsatisfactory results of the phase II clinical trials, various researchers have continued investigations into titanium-based drugs, sparking interest in the synthesis of secondgeneration titanocene and titanium(IV) complexes with anti-cancer properties [16][17][18][19][20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%
“…Structures eight titanocene steroid conjugates (26)(27)(28)(29)(30)(31)(32)(33) have been synthesized and structures have been characterized. [8,10,[44][45][46] The anti-proliferative activity of (26)(27)(28)(29)(30)(31)(32)(33) was determined in colon cancer HT29 and breast cancer MCF-7 cell lines. Titanocenyl containing cholesterol rings with IC 50 values over 200 μM, with the exception of complex (30) and highly active titanocenyls containing sex steroids with IC 50 values below 50 μM on MCF-7 cell line were reported.…”
Section: Titanocene Steroid Conjugatesmentioning
confidence: 99%
“…Organometallic and coordination titanium(IV) compounds are of interest due to their reactivity and uses including as reagents for catalytic enantioselective processes [1], organic transformations [2], as initiators for polymerization reactions [3], polymerisation catalysts [4][5][6][7][8][9][10] to metal organic frameworks [11][12][13] and metallo-supramolecular chemistry [14][15][16][17][18][19]. Other applications include the use of alkoxides or aryloxides precursors for the generation of titaniumbased materials [20][21][22][23][24][25][26] and their uses as photo-sensitisers and photo-catalysts [27,28], titaniumbased drugs [29][30][31][32][33][34][35][36][37][38][39] and cell imaging [40][41]. In recent years, substituted titanium-oxo-clusters, such as those substituted by acetylacetonate, carboxylates and catecholate derivatives, have attracted a great deal of attention, owing to their hydrolytic stability and versatile coordination modes [42][43][44]…”
Section: Introductionmentioning
confidence: 99%